|
Features: July 15, 2002
Gems of Genomic Genius
In separate feature stories, Business
Week showcased two Rensselaer alumni on the front lines
of biotechnology research. As president of The Institute
for Genomic Research (TIGR), Claire Fraser '77 is a front-runner
in finding the causes of disease through microbial sequencing.
Michael West '76, the head of Advanced Cell Technology Inc.,
is leading a charge to clone human embryos and attack such
diseases as Parkinson's, diabetes, or Alzheimer's.
Read the articles in Business Week:
"A
Genome Project Against Disease"
"Cloning:
Huckster or Hero?"
Title IX - 30 Years of Opportunity
In a USA Today article, Rensselaer President Shirley
Ann Jackson says that, on its 30th anniversary Title IX
is a vibrant policy offering unprecedented opportunities
for women in science and technology education. She calls
for universities to "build on the successes of Title
IX by creating affirmative opportunity" through programs
and policies that encourage women and minorities to pursue
high-tech fields.
More info: Women's
Athletics at Rensselaer and Title IX
A Two-Way Bridge
Too often we look at those on the other side of the "digital
divide" as poor people who have great needs but little
to give. That attitude, born of ignorance, puts us all at
a disadvantage, says Rensselaer Professor Ron Eglash in
an essay in the Chronicle of Higher Education.
Technologically and culturally, we have
much to learn from the other side, says Eglash, who calls
for a "two-way bridge."
Read the article in the Chronicle.
|
